Global Coccidiosis Vaccines Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Coccidiosis Vaccines Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Coccidiosis Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
  • 1.2.2 Attenuated Vaccines
  • 1.2.3 Non-attenuated Vaccines
• 1.3 Market by Application
  • 1.3.1 Global Coccidiosis Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
  • 1.3.2 Poultry
  • 1.3.3 Rabbit
  • 1.3.4 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Coccidiosis Vaccines Revenue Estimates and Forecasts 2019-2030
• 2.2 Global Coccidiosis Vaccines Revenue by Region
  • 2.2.1 Global Coccidiosis Vaccines Revenue by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Global Coccidiosis Vaccines Revenue by Region (2019-2024)
  • 2.2.3 Global Coccidiosis Vaccines Revenue by Region (2025-2030)
  • 2.2.4 Global Coccidiosis Vaccines Revenue Market Share by Region (2019-2030)
• 2.3 Global Coccidiosis Vaccines Sales Estimates and Forecasts 2019-2030
• 2.4 Global Coccidiosis Vaccines Sales by Region
  • 2.4.1 Global Coccidiosis Vaccines Sales by Region: 2019 VS 2023 VS 2030
  • 2.4.2 Global Coccidiosis Vaccines Sales by Region (2019-2024)
  • 2.4.3 Global Coccidiosis Vaccines Sales by Region (2025-2030)
  • 2.4.4 Global Coccidiosis Vaccines Sales Market Share by Region (2019-2030)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

• 3.1 Global Coccidiosis Vaccines Sales by Manufacturers
  • 3.1.1 Global Coccidiosis Vaccines Sales by Manufacturers (2019-2024)
  • 3.1.2 Global Coccidiosis Vaccines Sales Market Share by Manufacturers (2019-2024)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Coccidiosis Vaccines in 2023
• 3.2 Global Coccidiosis Vaccines Revenue by Manufacturers
  • 3.2.1 Global Coccidiosis Vaccines Revenue by Manufacturers (2019-2024)
  • 3.2.2 Global Coccidiosis Vaccines Revenue Market Share by Manufacturers (2019-2024)
  • 3.2.3 Global Top 10 and Top 5 Companies by Coccidiosis Vaccines Revenue in 2023
• 3.3 Global Key Players of Coccidiosis Vaccines, Industry Ranking, 2021 VS 2022
• 3.4 Global Coccidiosis Vaccines Sales Price by Manufacturers (2019-2024)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Coccidiosis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Coccidiosis Vaccines, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Coccidiosis Vaccines, Product Offered and Application
• 3.8 Global Key Manufacturers of Coccidiosis Vaccines, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Coccidiosis Vaccines Sales by Type
  • 4.1.1 Global Coccidiosis Vaccines Historical Sales by Type (2019-2024)
  • 4.1.2 Global Coccidiosis Vaccines Forecasted Sales by Type (2025-2030)
  • 4.1.3 Global Coccidiosis Vaccines Sales Market Share by Type (2019-2030)
• 4.2 Global Coccidiosis Vaccines Revenue by Type
  • 4.2.1 Global Coccidiosis Vaccines Historical Revenue by Type (2019-2024)
  • 4.2.2 Global Coccidiosis Vaccines Forecasted Revenue by Type (2025-2030)
  • 4.2.3 Global Coccidiosis Vaccines Revenue Market Share by Type (2019-2030)
• 4.3 Global Coccidiosis Vaccines Price by Type
  • 4.3.1 Global Coccidiosis Vaccines Price by Type (2019-2024)
  • 4.3.2 Global Coccidiosis Vaccines Price Forecast by Type (2025-2030)

5 Market Size by Application

• 5.1 Global Coccidiosis Vaccines Sales by Application
  • 5.1.1 Global Coccidiosis Vaccines Historical Sales by Application (2019-2024)
  • 5.1.2 Global Coccidiosis Vaccines Forecasted Sales by Application (2025-2030)
  • 5.1.3 Global Coccidiosis Vaccines Sales Market Share by Application (2019-2030)
• 5.2 Global Coccidiosis Vaccines Revenue by Application
  • 5.2.1 Global Coccidiosis Vaccines Historical Revenue by Application (2019-2024)
  • 5.2.2 Global Coccidiosis Vaccines Forecasted Revenue by Application (2025-2030)
  • 5.2.3 Global Coccidiosis Vaccines Revenue Market Share by Application (2019-2030)
• 5.3 Global Coccidiosis Vaccines Price by Application
  • 5.3.1 Global Coccidiosis Vaccines Price by Application (2019-2024)
  • 5.3.2 Global Coccidiosis Vaccines Price Forecast by Application (2025-2030)

6 US & Canada

• 6.1 US & Canada Coccidiosis Vaccines Market Size by Type
  • 6.1.1 US & Canada Coccidiosis Vaccines Sales by Type (2019-2030)
  • 6.1.2 US & Canada Coccidiosis Vaccines Revenue by Type (2019-2030)
• 6.2 US & Canada Coccidiosis Vaccines Market Size by Application
  • 6.2.1 US & Canada Coccidiosis Vaccines Sales by Application (2019-2030)
  • 6.2.2 US & Canada Coccidiosis Vaccines Revenue by Application (2019-2030)
• 6.3 US & Canada Coccidiosis Vaccines Market Size by Country
  • 6.3.1 US & Canada Coccidiosis Vaccines Revenue by Country: 2019 VS 2023 VS 2030
  • 6.3.2 US & Canada Coccidiosis Vaccines Revenue by Country (2019-2030)
  • 6.3.3 US & Canada Coccidiosis Vaccines Sales by Country (2019-2030)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Coccidiosis Vaccines Market Size by Type
  • 7.1.1 Europe Coccidiosis Vaccines Sales by Type (2019-2030)
  • 7.1.2 Europe Coccidiosis Vaccines Revenue by Type (2019-2030)
• 7.2 Europe Coccidiosis Vaccines Market Size by Application
  • 7.2.1 Europe Coccidiosis Vaccines Sales by Application (2019-2030)
  • 7.2.2 Europe Coccidiosis Vaccines Revenue by Application (2019-2030)
• 7.3 Europe Coccidiosis Vaccines Market Size by Country
  • 7.3.1 Europe Coccidiosis Vaccines Revenue by Country: 2019 VS 2023 VS 2030
  • 7.3.2 Europe Coccidiosis Vaccines Revenue by Country (2019-2030)
  • 7.3.3 Europe Coccidiosis Vaccines Sales by Country (2019-2030)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Coccidiosis Vaccines Market Size by Type
  • 8.1.1 China Coccidiosis Vaccines Sales by Type (2019-2030)
  • 8.1.2 China Coccidiosis Vaccines Revenue by Type (2019-2030)
• 8.2 China Coccidiosis Vaccines Market Size by Application
  • 8.2.1 China Coccidiosis Vaccines Sales by Application (2019-2030)
  • 8.2.2 China Coccidiosis Vaccines Revenue by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Coccidiosis Vaccines Market Size by Type
  • 9.1.1 Asia Coccidiosis Vaccines Sales by Type (2019-2030)
  • 9.1.2 Asia Coccidiosis Vaccines Revenue by Type (2019-2030)
• 9.2 Asia Coccidiosis Vaccines Market Size by Application
  • 9.2.1 Asia Coccidiosis Vaccines Sales by Application (2019-2030)
  • 9.2.2 Asia Coccidiosis Vaccines Revenue by Application (2019-2030)
• 9.3 Asia Coccidiosis Vaccines Market Size by Region
  • 9.3.1 Asia Coccidiosis Vaccines Revenue by Region: 2019 VS 2023 VS 2030
  • 9.3.2 Asia Coccidiosis Vaccines Revenue by Region (2019-2030)
  • 9.3.3 Asia Coccidiosis Vaccines Sales by Region (2019-2030)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India
  • 9.3.9 Australia

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Coccidiosis Vaccines Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Coccidiosis Vaccines Sales by Type (2019-2030)
  • 10.1.2 Middle East, Africa and Latin America Coccidiosis Vaccines Revenue by Type (2019-2030)
• 10.2 Middle East, Africa and Latin America Coccidiosis Vaccines Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Coccidiosis Vaccines Sales by Application (2019-2030)
  • 10.2.2 Middle East, Africa and Latin America Coccidiosis Vaccines Revenue by Application (2019-2030)
• 10.3 Middle East, Africa and Latin America Coccidiosis Vaccines Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America Coccidiosis Vaccines Revenue by Country: 2019 VS 2023 VS 2030
  • 10.3.2 Middle East, Africa and Latin America Coccidiosis Vaccines Revenue by Country (2019-2030)
  • 10.3.3 Middle East, Africa and Latin America Coccidiosis Vaccines Sales by Country (2019-2030)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Corporate Profile

• 11.1 MSD Animal Health
  • 11.1.1 MSD Animal Health Company Information
  • 11.1.2 MSD Animal Health Overview
  • 11.1.3 MSD Animal Health Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.1.4 MSD Animal Health Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 MSD Animal Health Recent Developments
• 11.2 Boehringer Ingelheim
  • 11.2.1 Boehringer Ingelheim Company Information
  • 11.2.2 Boehringer Ingelheim Overview
  • 11.2.3 Boehringer Ingelheim Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.2.4 Boehringer Ingelheim Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Boehringer Ingelheim Recent Developments
• 11.3 HIPRA
  • 11.3.1 HIPRA Company Information
  • 11.3.2 HIPRA Overview
  • 11.3.3 HIPRA Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.3.4 HIPRA Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 HIPRA Recent Developments
• 11.4 Bioproperties
  • 11.4.1 Bioproperties Company Information
  • 11.4.2 Bioproperties Overview
  • 11.4.3 Bioproperties Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.4.4 Bioproperties Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Bioproperties Recent Developments
• 11.5 Huvepharma
  • 11.5.1 Huvepharma Company Information
  • 11.5.2 Huvepharma Overview
  • 11.5.3 Huvepharma Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.5.4 Huvepharma Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Huvepharma Recent Developments
• 11.6 Nisseiken
  • 11.6.1 Nisseiken Company Information
  • 11.6.2 Nisseiken Overview
  • 11.6.3 Nisseiken Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.6.4 Nisseiken Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Nisseiken Recent Developments
• 11.7 Biopharm
  • 11.7.1 Biopharm Company Information
  • 11.7.2 Biopharm Overview
  • 11.7.3 Biopharm Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.7.4 Biopharm Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Biopharm Recent Developments
• 11.8 Ceva Sante Animale
  • 11.8.1 Ceva Sante Animale Company Information
  • 11.8.2 Ceva Sante Animale Overview
  • 11.8.3 Ceva Sante Animale Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.8.4 Ceva Sante Animale Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Ceva Sante Animale Recent Developments
• 11.9 Vaxxinova
  • 11.9.1 Vaxxinova Company Information
  • 11.9.2 Vaxxinova Overview
  • 11.9.3 Vaxxinova Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.9.4 Vaxxinova Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Vaxxinova Recent Developments
• 11.10 Foshan Standard Biotech
  • 11.10.1 Foshan Standard Biotech Company Information
  • 11.10.2 Foshan Standard Biotech Overview
  • 11.10.3 Foshan Standard Biotech Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.10.4 Foshan Standard Biotech Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Foshan Standard Biotech Recent Developments
• 11.11 Qilu Qingda Bio-Pharmaceutical
  • 11.11.1 Qilu Qingda Bio-Pharmaceutical Company Information
  • 11.11.2 Qilu Qingda Bio-Pharmaceutical Overview
  • 11.11.3 Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.11.4 Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Qilu Qingda Bio-Pharmaceutical Recent Developments
• 11.12 Skystar Bio-pharm
  • 11.12.1 Skystar Bio-pharm Company Information
  • 11.12.2 Skystar Bio-pharm Overview
  • 11.12.3 Skystar Bio-pharm Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.12.4 Skystar Bio-pharm Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Skystar Bio-pharm Recent Developments
• 11.13 Hlinte
  • 11.13.1 Hlinte Company Information
  • 11.13.2 Hlinte Overview
  • 11.13.3 Hlinte Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.13.4 Hlinte Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.13.5 Hlinte Recent Developments
• 11.14 Guangdong Winsun Bio-pharmaceutical
  • 11.14.1 Guangdong Winsun Bio-pharmaceutical Company Information
  • 11.14.2 Guangdong Winsun Bio-pharmaceutical Overview
  • 11.14.3 Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.14.4 Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.14.5 Guangdong Winsun Bio-pharmaceutical Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Coccidiosis Vaccines Industry Chain Analysis
• 12.2 Coccidiosis Vaccines Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Coccidiosis Vaccines Production Mode & Process
• 12.4 Coccidiosis Vaccines Sales and Marketing
  • 12.4.1 Coccidiosis Vaccines Sales Channels
  • 12.4.2 Coccidiosis Vaccines Distributors
• 12.5 Coccidiosis Vaccines Customers

13 Coccidiosis Vaccines Market Dynamics

• 13.1 Coccidiosis Vaccines Industry Trends
• 13.2 Coccidiosis Vaccines Market Drivers
• 13.3 Coccidiosis Vaccines Market Challenges
• 13.4 Coccidiosis Vaccines Market Restraints

14 Key Findings in the Global Coccidiosis Vaccines Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

Table 1. Global Coccidiosis Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Attenuated Vaccines

Table 3. Major Manufacturers of Non-attenuated Vaccines

Table 4. Global Coccidiosis Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Coccidiosis Vaccines Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Coccidiosis Vaccines Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Coccidiosis Vaccines Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Coccidiosis Vaccines Revenue Market Share by Region (2019-2024)

Table 9. Global Coccidiosis Vaccines Revenue Market Share by Region (2025-2030)

Table 10. Global Coccidiosis Vaccines Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Table 11. Global Coccidiosis Vaccines Sales by Region (2019-2024) & (K Units)

Table 12. Global Coccidiosis Vaccines Sales by Region (2025-2030) & (K Units)

Table 13. Global Coccidiosis Vaccines Sales Market Share by Region (2019-2024)

Table 14. Global Coccidiosis Vaccines Sales Market Share by Region (2025-2030)

Table 15. Global Coccidiosis Vaccines Sales by Manufacturers (2019-2024) & (K Units)

Table 16. Global Coccidiosis Vaccines Sales Share by Manufacturers (2019-2024)

Table 17. Global Coccidiosis Vaccines Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Coccidiosis Vaccines Revenue Market Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Coccidiosis Vaccines, Industry Ranking, 2021 VS 2022 VS 2023

Table 20. Coccidiosis Vaccines Price by Manufacturers (2019-2024) & (US$/Unit)

Table 21. Global Coccidiosis Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Coccidiosis Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coccidiosis Vaccines as of 2023)

Table 23. Global Key Manufacturers of Coccidiosis Vaccines, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Coccidiosis Vaccines, Product Offered and Application

Table 25. Global Key Manufacturers of Coccidiosis Vaccines, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Coccidiosis Vaccines Sales by Type (2019-2024) & (K Units)

Table 28. Global Coccidiosis Vaccines Sales by Type (2025-2030) & (K Units)

Table 29. Global Coccidiosis Vaccines Sales Share by Type (2019-2024)

Table 30. Global Coccidiosis Vaccines Sales Share by Type (2025-2030)

Table 31. Global Coccidiosis Vaccines Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Coccidiosis Vaccines Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Coccidiosis Vaccines Revenue Share by Type (2019-2024)

Table 34. Global Coccidiosis Vaccines Revenue Share by Type (2025-2030)

Table 35. Coccidiosis Vaccines Price by Type (2019-2024) & (US$/Unit)

Table 36. Global Coccidiosis Vaccines Price Forecast by Type (2025-2030) & (US$/Unit)

Table 37. Global Coccidiosis Vaccines Sales by Application (2019-2024) & (K Units)

Table 38. Global Coccidiosis Vaccines Sales by Application (2025-2030) & (K Units)

Table 39. Global Coccidiosis Vaccines Sales Share by Application (2019-2024)

Table 40. Global Coccidiosis Vaccines Sales Share by Application (2025-2030)

Table 41. Global Coccidiosis Vaccines Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Coccidiosis Vaccines Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Coccidiosis Vaccines Revenue Share by Application (2019-2024)

Table 44. Global Coccidiosis Vaccines Revenue Share by Application (2025-2030)

Table 45. Coccidiosis Vaccines Price by Application (2019-2024) & (US$/Unit)

Table 46. Global Coccidiosis Vaccines Price Forecast by Application (2025-2030) & (US$/Unit)

Table 47. US & Canada Coccidiosis Vaccines Sales by Type (2019-2024) & (K Units)

Table 48. US & Canada Coccidiosis Vaccines Sales by Type (2025-2030) & (K Units)

Table 49. US & Canada Coccidiosis Vaccines Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Coccidiosis Vaccines Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Coccidiosis Vaccines Sales by Application (2019-2024) & (K Units)

Table 52. US & Canada Coccidiosis Vaccines Sales by Application (2025-2030) & (K Units)

Table 53. US & Canada Coccidiosis Vaccines Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Coccidiosis Vaccines Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Coccidiosis Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Coccidiosis Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Coccidiosis Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Coccidiosis Vaccines Sales by Country (2019-2024) & (K Units)

Table 59. US & Canada Coccidiosis Vaccines Sales by Country (2025-2030) & (K Units)

Table 60. Europe Coccidiosis Vaccines Sales by Type (2019-2024) & (K Units)

Table 61. Europe Coccidiosis Vaccines Sales by Type (2025-2030) & (K Units)

Table 62. Europe Coccidiosis Vaccines Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Coccidiosis Vaccines Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Coccidiosis Vaccines Sales by Application (2019-2024) & (K Units)

Table 65. Europe Coccidiosis Vaccines Sales by Application (2025-2030) & (K Units)

Table 66. Europe Coccidiosis Vaccines Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Coccidiosis Vaccines Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Coccidiosis Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Coccidiosis Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Coccidiosis Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Coccidiosis Vaccines Sales by Country (2019-2024) & (K Units)

Table 72. Europe Coccidiosis Vaccines Sales by Country (2025-2030) & (K Units)

Table 73. China Coccidiosis Vaccines Sales by Type (2019-2024) & (K Units)

Table 74. China Coccidiosis Vaccines Sales by Type (2025-2030) & (K Units)

Table 75. China Coccidiosis Vaccines Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Coccidiosis Vaccines Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Coccidiosis Vaccines Sales by Application (2019-2024) & (K Units)

Table 78. China Coccidiosis Vaccines Sales by Application (2025-2030) & (K Units)

Table 79. China Coccidiosis Vaccines Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Coccidiosis Vaccines Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Coccidiosis Vaccines Sales by Type (2019-2024) & (K Units)

Table 82. Asia Coccidiosis Vaccines Sales by Type (2025-2030) & (K Units)

Table 83. Asia Coccidiosis Vaccines Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Coccidiosis Vaccines Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Coccidiosis Vaccines Sales by Application (2019-2024) & (K Units)

Table 86. Asia Coccidiosis Vaccines Sales by Application (2025-2030) & (K Units)

Table 87. Asia Coccidiosis Vaccines Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Coccidiosis Vaccines Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Coccidiosis Vaccines Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Coccidiosis Vaccines Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Coccidiosis Vaccines Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Coccidiosis Vaccines Sales by Region (2019-2024) & (K Units)

Table 93. Asia Coccidiosis Vaccines Sales by Region (2025-2030) & (K Units)

Table 94. Middle East, Africa and Latin America Coccidiosis Vaccines Sales by Type (2019-2024) & (K Units)

Table 95. Middle East, Africa and Latin America Coccidiosis Vaccines Sales by Type (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Coccidiosis Vaccines Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Coccidiosis Vaccines Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Coccidiosis Vaccines Sales by Application (2019-2024) & (K Units)

Table 99. Middle East, Africa and Latin America Coccidiosis Vaccines Sales by Application (2025-2030) & (K Units)

Table 100. Middle East, Africa and Latin America Coccidiosis Vaccines Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Coccidiosis Vaccines Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Coccidiosis Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Coccidiosis Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Coccidiosis Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Coccidiosis Vaccines Sales by Country (2019-2024) & (K Units)

Table 106. Middle East, Africa and Latin America Coccidiosis Vaccines Sales by Country (2025-2030) & (K Units)

Table 107. MSD Animal Health Company Information

Table 108. MSD Animal Health Description and Major Businesses

Table 109. MSD Animal Health Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. MSD Animal Health Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. MSD Animal Health Recent Developments

Table 112. Boehringer Ingelheim Company Information

Table 113. Boehringer Ingelheim Description and Major Businesses

Table 114. Boehringer Ingelheim Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Boehringer Ingelheim Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Boehringer Ingelheim Recent Developments

Table 117. HIPRA Company Information

Table 118. HIPRA Description and Major Businesses

Table 119. HIPRA Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. HIPRA Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. HIPRA Recent Developments

Table 122. Bioproperties Company Information

Table 123. Bioproperties Description and Major Businesses

Table 124. Bioproperties Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. Bioproperties Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Bioproperties Recent Developments

Table 127. Huvepharma Company Information

Table 128. Huvepharma Description and Major Businesses

Table 129. Huvepharma Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 130. Huvepharma Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Huvepharma Recent Developments

Table 132. Nisseiken Company Information

Table 133. Nisseiken Description and Major Businesses

Table 134. Nisseiken Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 135. Nisseiken Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Nisseiken Recent Developments

Table 137. Biopharm Company Information

Table 138. Biopharm Description and Major Businesses

Table 139. Biopharm Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 140. Biopharm Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Biopharm Recent Developments

Table 142. Ceva Sante Animale Company Information

Table 143. Ceva Sante Animale Description and Major Businesses

Table 144. Ceva Sante Animale Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 145. Ceva Sante Animale Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. Ceva Sante Animale Recent Developments

Table 147. Vaxxinova Company Information

Table 148. Vaxxinova Description and Major Businesses

Table 149. Vaxxinova Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 150. Vaxxinova Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 151. Vaxxinova Recent Developments

Table 152. Foshan Standard Biotech Company Information

Table 153. Foshan Standard Biotech Description and Major Businesses

Table 154. Foshan Standard Biotech Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 155. Foshan Standard Biotech Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 156. Foshan Standard Biotech Recent Developments

Table 157. Qilu Qingda Bio-Pharmaceutical Company Information

Table 158. Qilu Qingda Bio-Pharmaceutical Description and Major Businesses

Table 159. Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 160. Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 161. Qilu Qingda Bio-Pharmaceutical Recent Developments

Table 162. Skystar Bio-pharm Company Information

Table 163. Skystar Bio-pharm Description and Major Businesses

Table 164. Skystar Bio-pharm Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 165. Skystar Bio-pharm Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 166. Skystar Bio-pharm Recent Developments

Table 167. Hlinte Company Information

Table 168. Hlinte Description and Major Businesses

Table 169. Hlinte Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 170. Hlinte Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 171. Hlinte Recent Developments

Table 172. Guangdong Winsun Bio-pharmaceutical Company Information

Table 173. Guangdong Winsun Bio-pharmaceutical Description and Major Businesses

Table 174. Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 175. Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 176. Guangdong Winsun Bio-pharmaceutical Recent Developments

Table 177. Key Raw Materials Lists

Table 178. Raw Materials Key Suppliers Lists

Table 179. Coccidiosis Vaccines Distributors List

Table 180. Coccidiosis Vaccines Customers List

Table 181. Coccidiosis Vaccines Market Trends

Table 182. Coccidiosis Vaccines Market Drivers

Table 183. Coccidiosis Vaccines Market Challenges

Table 184. Coccidiosis Vaccines Market Restraints

Table 185. Research Programs/Design for This Report

Table 186. Key Data Information from Secondary Sources

Table 187. Key Data Information from Primary Sources

List of Figures

Figure 1. Coccidiosis Vaccines Product Picture

Figure 2. Global Coccidiosis Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Coccidiosis Vaccines Market Share by Type: 2023 & 2030

Figure 4. Attenuated Vaccines Product Picture

Figure 5. Non-attenuated Vaccines Product Picture

Figure 6. Global Coccidiosis Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Coccidiosis Vaccines Market Share by Application: 2023 & 2030

Figure 8. Poultry

Figure 9. Rabbit

Figure 10. Others

Figure 11. Coccidiosis Vaccines Report Years Considered

Figure 12. Global Coccidiosis Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Coccidiosis Vaccines Revenue (2019-2030) & (US$ Million)

Figure 14. Global Coccidiosis Vaccines Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 15. Global Coccidiosis Vaccines Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 16. Global Coccidiosis Vaccines Revenue Market Share by Region (2019-2030)

Figure 17. Global Coccidiosis Vaccines Sales (2019-2030) & (K Units)

Figure 18. Global Coccidiosis Vaccines Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Figure 19. Global Coccidiosis Vaccines Sales Market Share by Region (2019-2030)

Figure 20. US & Canada Coccidiosis Vaccines Sales YoY (2019-2030) & (K Units)

Figure 21. US & Canada Coccidiosis Vaccines Revenue YoY (2019-2030) & (US$ Million)

Figure 22. Europe Coccidiosis Vaccines Sales YoY (2019-2030) & (K Units)

Figure 23. Europe Coccidiosis Vaccines Revenue YoY (2019-2030) & (US$ Million)

Figure 24. China Coccidiosis Vaccines Sales YoY (2019-2030) & (K Units)

Figure 25. China Coccidiosis Vaccines Revenue YoY (2019-2030) & (US$ Million)

Figure 26. Asia (excluding China) Coccidiosis Vaccines Sales YoY (2019-2030) & (K Units)

Figure 27. Asia (excluding China) Coccidiosis Vaccines Revenue YoY (2019-2030) & (US$ Million)

Figure 28. Middle East, Africa and Latin America Coccidiosis Vaccines Sales YoY (2019-2030) & (K Units)

Figure 29. Middle East, Africa and Latin America Coccidiosis Vaccines Revenue YoY (2019-2030) & (US$ Million)

Figure 30. Global Coccidiosis Vaccines Sales Share by Manufacturers (2023)

Figure 31. The Coccidiosis Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 32. Global Coccidiosis Vaccines Revenue Share by Manufacturers (2023)

Figure 33. The Top 5 and 10 Largest Manufacturers of Coccidiosis Vaccines in the World: Market Share by Coccidiosis Vaccines Revenue in 2023

Figure 34. Global Coccidiosis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 35. Global Coccidiosis Vaccines Sales Market Share by Type (2019-2030)

Figure 36. Global Coccidiosis Vaccines Revenue Market Share by Type (2019-2030)

Figure 37. Global Coccidiosis Vaccines Sales Market Share by Application (2019-2030)

Figure 38. Global Coccidiosis Vaccines Revenue Market Share by Application (2019-2030)

Figure 39. US & Canada Coccidiosis Vaccines Sales Market Share by Type (2019-2030)

Figure 40. US & Canada Coccidiosis Vaccines Revenue Market Share by Type (2019-2030)

Figure 41. US & Canada Coccidiosis Vaccines Sales Market Share by Application (2019-2030)

Figure 42. US & Canada Coccidiosis Vaccines Revenue Market Share by Application (2019-2030)

Figure 43. US & Canada Coccidiosis Vaccines Revenue Share by Country (2019-2030)

Figure 44. US & Canada Coccidiosis Vaccines Sales Share by Country (2019-2030)

Figure 45. US Coccidiosis Vaccines Revenue (2019-2030) & (US$ Million)

Figure 46. Canada Coccidiosis Vaccines Revenue (2019-2030) & (US$ Million)

Figure 47. Europe Coccidiosis Vaccines Sales Market Share by Type (2019-2030)

Figure 48. Europe Coccidiosis Vaccines Revenue Market Share by Type (2019-2030)

Figure 49. Europe Coccidiosis Vaccines Sales Market Share by Application (2019-2030)

Figure 50. Europe Coccidiosis Vaccines Revenue Market Share by Application (2019-2030)

Figure 51. Europe Coccidiosis Vaccines Revenue Share by Country (2019-2030)

Figure 52. Europe Coccidiosis Vaccines Sales Share by Country (2019-2030)

Figure 53. Germany Coccidiosis Vaccines Revenue (2019-2030) & (US$ Million)

Figure 54. France Coccidiosis Vaccines Revenue (2019-2030) & (US$ Million)

Figure 55. U.K. Coccidiosis Vaccines Revenue (2019-2030) & (US$ Million)

Figure 56. Italy Coccidiosis Vaccines Revenue (2019-2030) & (US$ Million)

Figure 57. Russia Coccidiosis Vaccines Revenue (2019-2030) & (US$ Million)

Figure 58. China Coccidiosis Vaccines Sales Market Share by Type (2019-2030)

Figure 59. China Coccidiosis Vaccines Revenue Market Share by Type (2019-2030)

Figure 60. China Coccidiosis Vaccines Sales Market Share by Application (2019-2030)

Figure 61. China Coccidiosis Vaccines Revenue Market Share by Application (2019-2030)

Figure 62. Asia Coccidiosis Vaccines Sales Market Share by Type (2019-2030)

Figure 63. Asia Coccidiosis Vaccines Revenue Market Share by Type (2019-2030)

Figure 64. Asia Coccidiosis Vaccines Sales Market Share by Application (2019-2030)

Figure 65. Asia Coccidiosis Vaccines Revenue Market Share by Application (2019-2030)

Figure 66. Asia Coccidiosis Vaccines Revenue Share by Region (2019-2030)

Figure 67. Asia Coccidiosis Vaccines Sales Share by Region (2019-2030)

Figure 68. Japan Coccidiosis Vaccines Revenue (2019-2030) & (US$ Million)

Figure 69. South Korea Coccidiosis Vaccines Revenue (2019-2030) & (US$ Million)

Figure 70. China Taiwan Coccidiosis Vaccines Revenue (2019-2030) & (US$ Million)

Figure 71. Southeast Asia Coccidiosis Vaccines Revenue (2019-2030) & (US$ Million)

Figure 72. India Coccidiosis Vaccines Revenue (2019-2030) & (US$ Million)

Figure 73. Australia Coccidiosis Vaccines Revenue (2019-2030) & (US$ Million)

Figure 74. Middle East, Africa and Latin America Coccidiosis Vaccines Sales Market Share by Type (2019-2030)

Figure 75. Middle East, Africa and Latin America Coccidiosis Vaccines Revenue Market Share by Type (2019-2030)

Figure 76. Middle East, Africa and Latin America Coccidiosis Vaccines Sales Market Share by Application (2019-2030)

Figure 77. Middle East, Africa and Latin America Coccidiosis Vaccines Revenue Market Share by Application (2019-2030)

Figure 78. Middle East, Africa and Latin America Coccidiosis Vaccines Revenue Share by Country (2019-2030)

Figure 79. Middle East, Africa and Latin America Coccidiosis Vaccines Sales Share by Country (2019-2030)

Figure 80. Brazil Coccidiosis Vaccines Revenue (2019-2030) & (US$ Million)

Figure 81. Mexico Coccidiosis Vaccines Revenue (2019-2030) & (US$ Million)

Figure 82. Turkey Coccidiosis Vaccines Revenue (2019-2030) & (US$ Million)

Figure 83. Israel Coccidiosis Vaccines Revenue (2019-2030) & (US$ Million)

Figure 84. GCC Countries Coccidiosis Vaccines Revenue (2019-2030) & (US$ Million)

Figure 85. Coccidiosis Vaccines Value Chain

Figure 86. Coccidiosis Vaccines Production Process

Figure 87. Channels of Distribution (Direct Vs Distribution)

Figure 88. Bottom-up and Top-down Approaches for This Report

Figure 89. Data Triangulation

Figure 90. Key Executives Interviewed